Granahan Investment Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Granahan Investment Management’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-187,515	Closed	-$159K	–	259
2015 Q3	$159K	Sell	187,515 -8,400	-4%	-$9.52K	﹤0.01%	254
2015 Q2	$280K	Sell	195,915 -130,014	-40%	-$318K	0.01%	236
2015 Q1	$1.06M	Sell	325,929 -22,955	-7%	-$78.2K	0.03%	225
2014 Q4	$1.11M	Hold	348,884	–	–	0.03%	201
2014 Q3	$2.83M	Sell	348,884 -11,511	-3%	-$94.2K	0.09%	185
2014 Q2	$3.77M	Sell	360,395 -20,000	-5%	-$170K	0.11%	177
2014 Q1	$3.45M	Buy	380,395 +7,760	+2%	+$46K	0.09%	185
2013 Q4	$1.77M	Buy	+372,635	New	+$1.74M	0.05%	200

Other funds holding BSTG

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TSP

Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

WIC

Woodmont Investment Counsel Nashville, Tennessee $1.83B AUM 25.91% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Granahan Investment Management's BSTG Position: Q4 2015 in Review

Granahan Investment Management sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2015, closing a stake of 187,515 shares — an estimated $159K sold.

Granahan Investment Management first reported a position in BSTG in Q4 2013 and held it in 8 quarters. The position peaked at $3.77M in Q2 2014. 28 funds tracked by Wall St. Rank hold BSTG as of Q4 2015.

Granahan Investment Management reported no remaining Biostage, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
Granahan Investment Management sold 187,515 Biostage, Inc. Common Stock shares in Q4 2015, an estimated $159K.
Granahan Investment Management first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 8 quarters.
Granahan Investment Management's Biostage, Inc. Common Stock position peaked at $3.77M in Q2 2014.
28 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2015.

Based on Granahan Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.